These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1279 related items for PubMed ID: 21993310

  • 1. S14G-humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice.
    Zhang W, Zhang W, Li Z, Hao J, Zhang Z, Liu L, Mao N, Miao J, Zhang L.
    Pharmacol Biochem Behav; 2012 Jan; 100(3):361-9. PubMed ID: 21993310
    [Abstract] [Full Text] [Related]

  • 2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W, Hao J, Liu R, Zhang Z, Lei G, Su C, Miao J, Li Z.
    Behav Brain Res; 2011 Sep 23; 222(2):342-50. PubMed ID: 21513747
    [Abstract] [Full Text] [Related]

  • 3. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Sierksma AS, Rutten K, Sydlik S, Rostamian S, Steinbusch HW, van den Hove DL, Prickaerts J.
    Neuropharmacology; 2013 Jan 23; 64():124-36. PubMed ID: 22771768
    [Abstract] [Full Text] [Related]

  • 4. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y, Strehaiano M, Rodríguez Obaya T, García Rodríguez JC, Maurice T.
    J Alzheimers Dis; 2017 Jan 23; 55(1):231-248. PubMed ID: 27662300
    [Abstract] [Full Text] [Related]

  • 5. Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms.
    Du Y, Qu J, Zhang W, Bai M, Zhou Q, Zhang Z, Li Z, Miao J.
    Neuropharmacology; 2016 Sep 23; 108():1-13. PubMed ID: 27067919
    [Abstract] [Full Text] [Related]

  • 6. S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice.
    Miao J, Zhang W, Yin R, Liu R, Su C, Lei G, Li Z.
    Neuropeptides; 2008 Sep 23; 42(5-6):557-67. PubMed ID: 18929410
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D, Flunkert S, Neddens J, Duller S, Scopes DIC, Treherne JM, Hutter-Paier B.
    Neurosci Lett; 2017 Nov 01; 660():96-102. PubMed ID: 28917978
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W, Du Y, Bai M, Xi Y, Li Z, Miao J.
    J Pept Sci; 2013 Mar 01; 19(3):159-65. PubMed ID: 23349038
    [Abstract] [Full Text] [Related]

  • 11. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
    Zhang W, Bai M, Xi Y, Hao J, Liu L, Mao N, Su C, Miao J, Li Z.
    Free Radic Biol Med; 2012 Apr 15; 52(8):1443-52. PubMed ID: 22342520
    [Abstract] [Full Text] [Related]

  • 12. Changes in the brain and plasma Aβ peptide levels with age and its relationship with cognitive impairment in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Izco M, Martínez P, Corrales A, Fandos N, García S, Insua D, Montañes M, Pérez-Grijalba V, Rueda N, Vidal V, Martínez-Cué C, Pesini P, Sarasa M.
    Neuroscience; 2014 Mar 28; 263():269-79. PubMed ID: 24447596
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, Price DL, Tang F, Markowska AL, Borchelt DR.
    Neurobiol Dis; 2005 Apr 28; 18(3):602-17. PubMed ID: 15755686
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Effects of Cardiotrophin-1 on Early Synaptic Mitochondrial Dysfunction and Synaptic Pathology in APPswe/PS1dE9 Mice.
    Wang D, Liu X, Liu Y, Li S, Wang C.
    J Alzheimers Dis; 2017 Apr 28; 59(4):1255-1267. PubMed ID: 28731433
    [Abstract] [Full Text] [Related]

  • 17. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
    Seo JS, Jung EY, Kim JH, Lyu YS, Han PL, Kang HW.
    J Ethnopharmacol; 2010 Aug 09; 130(3):578-85. PubMed ID: 20669372
    [Abstract] [Full Text] [Related]

  • 18. S14G-humanin alleviates insulin resistance and increases autophagy in neurons of APP/PS1 transgenic mouse.
    Han K, Jia N, Zhong Y, Shang X.
    J Cell Biochem; 2018 Apr 09; 119(4):3111-3117. PubMed ID: 29058763
    [Abstract] [Full Text] [Related]

  • 19. Progressive Spatial Memory Impairment, Brain Amyloid Deposition and Changes in Serum Amyloid Levels as a Function of Age in APPswe/PS1dE9 Mice.
    Fu L, Sun Y, Guo Y, Yu B, Zhang H, Wu J, Yu X, Wu H, Kong W.
    Curr Alzheimer Res; 2018 Apr 09; 15(11):1053-1061. PubMed ID: 29984654
    [Abstract] [Full Text] [Related]

  • 20. Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    Reale M, D'Angelo C, Costantini E, Di Nicola M, Yarla NS, Kamal MA, Salvador N, Perry G.
    J Alzheimers Dis; 2018 Apr 09; 62(1):467-476. PubMed ID: 29439355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.